Your new experience awaits. Try the new design now and help us make it even better

RETRACTION article

Front. Pharmacol., 29 January 2026

Sec. Experimental Pharmacology and Drug Discovery

Volume 17 - 2026 | https://doi.org/10.3389/fphar.2026.1791496

Retraction: Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

This article is a retraction of:

  1. RETRACTED: Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

    1. Read original article
Frontiers Editorial Office Frontiers Editorial Office*

A Retraction of the Original Research article
Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1

by Situmorang PC, Ilyas S, Syahputra RA, Sari RM, Nugraha AP and Ibrahim A (2024). Front. Pharmacol. 15:1345645. doi: 10.3389/fphar.2024.1345645

The Journal retracts the 2024 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures on PubPeer, where several partial duplications across Figures 5–8 are documented.

The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable, and the article has been retracted.

This retraction was approved by the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.

Frontiers would like to thank Sholto David for contacting the journal regarding the published article.

Citation: Frontiers Editorial Office (2026) Retraction: Rhodomyrtus tomentosa as a new anticancer molecular strategy in breast histology via Her2, IL33, EGFR, and MUC1. Front. Pharmacol. 17:1791496. doi: 10.3389/fphar.2026.1791496

Received: 19 January 2026; Accepted: 19 January 2026;
Published: 29 January 2026.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2026 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiersial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.